Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Global health initiatives news

Show

From To
“Dialogue” Highlighted As Way Forward At Closure Of WHO Fair Pricing Forum

WHO said that it will launch a public online consultation involving governments, industry and civil society to try to come up with a broad consensus on what actually constitutes a “fair price” for essential medicines.

Published
15 April 2019
From
Health Policy Watch
UN Whistleblower Targeted in Misconduct Probe

Confidential documents obtained by The Associated Press show UNAIDS is grappling with previously unreported allegations of financial and sexual misconduct involving Martina Brostrom, who went public last March with claims that one of the organization's top officials assaulted her in 2015. As part of a preliminary internal inquiry, investigators for the World Health Organization, which oversees UNAIDS, wrote that they had found "evidence" that Brostrom and her former supervisor may have taken part in "fraudulent practices and misuse of travel funds," the documents show.

Published
15 April 2019
From
U.S. News and World Report
South Africa: Health department scrambles to stop US cut in HIV funds

In a surprise move barely six weeks after announcing that SA was to get an extra $1.2bn to support its HIV/AIDS programmes over the next two years, US global AIDS coordinator Deborah Birx said Pepfar’s programmes are performing so poorly in SA that funding should be cut from the start of the next US financial year, which begins on October 1.

Published
12 April 2019
From
Business Day
Avoiding Dolutegravir in Young Women With HIV: Time for a Rethink?

Total deaths for women with HIV and their children are projected to be lower with dolutegravir-based (Tivicay) antiretroviral therapy (ART) versus efavirenz-based (Sustiva) ART, a model-based analysis found.

Published
05 April 2019
From
MedPage Today
Interview With Charles Gore, Medicines Patent Pool Executive Director

Charles Gore took over the role of Executive Director at the Medicines Patent Pool in July 2018, just after its board decided to greatly expand its mandate into essential medicines. Nine months into his term, IP-Watch’s William New talked with him about his role and how the expansion is going.

Published
24 March 2019
From
Intellectual Property Watch
New UN guidelines to mainstream human rights in the global drugs debate

In early March, the Chief Executives Board of the United Nations, representing 31 UN agencies – including the World Health Organisation, UNICEF, the High Commissioner for Human Rights and the UN Office on Drugs and Crime – adopted a common position on drug policy. Among the actions agreed is was a commitment to “support the development and implementation of policies that put people, health and human rights at the centre … and to promote a rebalancing of drug policies and interventions towards public health approaches”.

Published
19 March 2019
From
The Conversation
Trump Budget Proposes Largest Ever Cuts to Global HIV Programs

Just one month ago, President Trump promised during the State of the Union Address to defeat HIV in the U.S. and beyond. But the president’s budget proposal to Congress today—which threatens to gut life-saving HIV treatment and prevention programs—unmasks his lies. If implemented, Trump’s proposal would wipe out years of progress in the effort to end the AIDS pandemic.

Published
14 March 2019
From
Health GAP
TAG statement on the President’s FY 2020 budget proposal

Treatment Action Group (TAG) opposes the President’s Fiscal Year (FY) 2020 budget proposal, which makes a mockery of the administration’s purported strategy to end AIDS in the United States over the next decade. TAG welcomes additional investments in HIV prevention and treatment towards eliminating HIV in the U.S. However, the federal budget’s defunding equally important areas across domestic and global health programs, social services, and research raises tremendous doubt about the administration’s commitment to end HIV. We are also concerned about the fate of related epidemics such as hepatitis C (HCV) and tuberculosis (TB).

Published
14 March 2019
From
TAG
Trump’s Budget Offers $291M To Fight HIV In U.S. But Trims Overseas Efforts

The Trump administration took another step toward fulfilling its goal of ending the HIV epidemic in the United States Monday by requesting $291 million for its initiative in the White House’s annual budget. But within the budget, the administration also proposed actions that could undermine efforts to control the virus’s spread, HIV experts and advocates said, including carving out funds from programs that aim to eradicate HIV in other parts of the world.

Published
12 March 2019
From
Kaiser Health News
HIV charity unveils new name and logo

International HIV/AIDS Alliance has unveiled its rebrand with a new name, Frontline Aids, and new logo. The charity said that the move comes as part of wider strategy changes to try to boost funding, social change and political awareness of Aids.

Published
28 February 2019
From
Civil Society Media
← First12345...89Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.